Fund Information
Overview
The Company's investment objective is to target absolute returns of at least 10 percent to 15 percent per annum over any five-year period with low correlation to traditional equity benchmarks and an annualised volatility target of less than 8 percent whilst preserving capital in all market conditions. The Company will seek to achieve its investment objective through investment in an actively managed portfolio of hedge funds, diversified by investment strategy, style and manager. The Company's shares are denominated in Sterling and the Company implements a hedging policy to protect the Sterling value of its US Dollar denominated investments.
Key Facts
Manager
Dexion Capital (Guernsey) Limited
Investment Adviser
K2 Advisors LLC
Investment Consultant
Dexion Capital plc
Total Net Assets (as at 29-Jan-10)
£80.45M
Latest Share Price & NAV
| Last | Bid | Offer | NAV** | |
| GBX | 111.000 | 111.500 | 112.250 | 127.120 |
As at 19:50:01 11-Mar-2010
*Delayed by 15 minutes
**NAV estimated as at 05-Mar-10
Contact Details
Email
clientservices@dexionequity.com
Telephone
+44 1481 743940
Download Historical Data
NAV/Performance
DEAL Monthly Data.xls
Share Price
DEAL Daily Shareprice.xls
Performance Data
| 29-Jan-10 |
January (%) |
YTD (%) |
ITD * (%) |
Volatility *(%) |
Sharpe *ˆ |
|
| Dexion Equity Alternative £ Share NAV | 125.72 | -0.85 | -0.85 | 4.32 | 5.43 | 0.01 |
| HFRI Fund of Funds Index (US$) | -0.36 | -0.36 | 2.93 | 6.36 | -0.02 | |
| MSCI World Index Gross (TR) (US$) | -4.11 | -4.11 | 3.48 | 16.72 | 0.02 | |
| JPM Global Gov’t Bond Index (TR) (US$) | 0.51 | 0.51 | 5.40 | 7.52 | 0.31 | |
* Annualised from inception date of DEA £, based on monthly data.
|
||||||
Share Class
| Inception Date | Bloomberg | Reuters | Isin | Sedol | Total Net Assets | |
| £ | 1 April 2004 | DEA LN | DEA.L | GB0034312321 | 3431232 | £80.45M |
Net Asset Value Performance
✝ Chart data as at 29-Jan-10
Share Price Performance
✝ Chart data as at 29-Jan-10
Portfolio Allocation
✝ Chart data as at 29-Jan-10
Performance By Strategy
✝ Chart data as at 29-Jan-10
Site issued and operated by Dexion Capital. Dexion Capital is registered in England and Wales under company number 4040660 and has its registered office at 9 Bridewell Place, London EC4V 6AW.
Dexion Capital is authorised and regulated by the Financial Services Authority and provides services and markets securities in the United Kingdom and certain E.U. and other non-U.S. jurisdictions. The contents of this site may only be accessed by certain categories of persons and are not available to all persons. Dexion closed-end funds are not registered under the U.S. Securities Act of 1933 or the Investment Company Act of 1940 and are not being offered or sold in the U.S.